These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
220 related items for PubMed ID: 10376440
1. T cell reactivity to DR*0401- and DQ*0302-binding peptides of the putative autoantigen IA-2 in type 1 diabetes. Lohmann T, Halder T, Engler J, Morgenthaler NG, Khoo-Morgenthaler UY, Schröder S, Seissler J, Scherbaum WA, Kalbacher H. Exp Clin Endocrinol Diabetes; 1999; 107(3):166-71. PubMed ID: 10376440 [Abstract] [Full Text] [Related]
2. IA-2 (islet cell antigen 512) is the primary target of humoral autoimmunity against type 1 diabetes-associated tyrosine phosphatase autoantigens. Bonifacio E, Lampasona V, Bingley PJ. J Immunol; 1998 Sep 01; 161(5):2648-54. PubMed ID: 9725268 [Abstract] [Full Text] [Related]
4. Autoantibodies in insulin-dependent diabetes recognize distinct cytoplasmic domains of the protein tyrosine phosphatase-like IA-2 autoantigen. Lampasona V, Bearzatto M, Genovese S, Bosi E, Ferrari M, Bonifacio E. J Immunol; 1996 Sep 15; 157(6):2707-11. PubMed ID: 8805677 [Abstract] [Full Text] [Related]
5. Enterovirus infection may induce humoral immune response reacting with islet cell autoantigens in humans. Härkönen T, Paananen A, Lankinen H, Hovi T, Vaarala O, Roivainen M. J Med Virol; 2003 Mar 15; 69(3):426-40. PubMed ID: 12526055 [Abstract] [Full Text] [Related]
6. Evidence for molecular mimicry between human T cell epitopes in rotavirus and pancreatic islet autoantigens. Honeyman MC, Stone NL, Falk BA, Nepom G, Harrison LC. J Immunol; 2010 Feb 15; 184(4):2204-10. PubMed ID: 20083660 [Abstract] [Full Text] [Related]
8. Increased in vivo frequency of IA-2 peptide-reactive IFNgamma+/IL-4- T cells in type 1 diabetic subjects. Herzog BA, Ott PA, Dittrich MT, Quast S, Karulin AY, Kalbacher H, Karges W, Tary-Lehmann M, Lehmann PV, Boehm BO, Durinovic-Belló I. J Autoimmun; 2004 Aug 15; 23(1):45-54. PubMed ID: 15236752 [Abstract] [Full Text] [Related]
9. Autoantibodies and associated T-cell responses to determinants within the 831-860 region of the autoantigen IA-2 in Type 1 diabetes. Weenink SM, Lo J, Stephenson CR, McKinney PA, Ananieva-Jordanova R, Rees Smith B, Furmaniak J, Tremble JM, Bodansky HJ, Christie MR. J Autoimmun; 2009 Sep 15; 33(2):147-54. PubMed ID: 19447008 [Abstract] [Full Text] [Related]
11. Comparison of IA-2 with IA-2beta and with six other members of the protein tyrosine phosphatase family: recognition of antigenic determinants by IDDM sera. Notkins AL, Zhang B, Matsumoto Y, Lan MS. J Autoimmun; 1997 Jun 15; 10(3):245-50. PubMed ID: 9218750 [Abstract] [Full Text] [Related]
12. Early development and spreading of autoantibodies to epitopes of IA-2 and their association with progression to type 1 diabetes. Naserke HE, Ziegler AG, Lampasona V, Bonifacio E. J Immunol; 1998 Dec 15; 161(12):6963-9. PubMed ID: 9862731 [Abstract] [Full Text] [Related]
18. T-cell epitopes in type 1 diabetes autoantigen tyrosine phosphatase IA-2: potential for mimicry with rotavirus and other environmental agents. Honeyman MC, Stone NL, Harrison LC. Mol Med; 1998 Apr 15; 4(4):231-9. PubMed ID: 9606176 [Abstract] [Full Text] [Related]
19. ICA512(IA-2) epitope specific assays distinguish transient from diabetes associated autoantibodies. Miao D, Yu L, Tiberti C, Cuthbertson DD, Rewers M, di Mario U, Eisenbarth GS, Dotta F. J Autoimmun; 2002 Mar 15; 18(2):191-6. PubMed ID: 11908951 [Abstract] [Full Text] [Related]
20. Isolation and characterisation of a human monoclonal autoantibody to the islet cell autoantigen IA-2. Ananieva-Jordanova R, Evans M, Nakamatsu T, Premawardhana LD, Sanders J, Powell M, Chen S, McGrath V, Belton C, Arnold C, Baker S, Betterle C, Zanchetta R, Smith BR, Furmaniak J. J Autoimmun; 2005 Jun 15; 24(4):337-45. PubMed ID: 15869863 [Abstract] [Full Text] [Related] Page: [Next] [New Search]